Skip to main content
. Author manuscript; available in PMC: 2016 Jul 8.
Published in final edited form as: Circ Res. 2016 Jan 8;118(1):145–156. doi: 10.1161/CIRCRESAHA.115.306656

Figure 4.

Figure 4

Mendelian Randomization studies demonstrate that polymorphism in the IL-6 signaling pathway at rs2228145 and rs7529229 concordantly associate with both lifetime lower levels of hsCRP and lifetime lower risks of coronary heart disease. Adapted from Lancet 2012;379:1214-24 and Lancet 2012;379:1205-13.